News Plus Therapeutics Receives $1.9 Million Advance Payment from CPRIT and Plans to Present at the CPRIT Innovations in Cancer Prevention and Research Conference Staff September 11, 2023 Iframe sync Post navigation Previous: Veru Reports Clinical Data from the Discontinued ARTEST Study of Enobosarm, Novel Selective Androgen Receptor Targeting Agonist, in AR+ ER+ HER2- Metastatic Breast CancerNext: Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 More Stories Healthcare Medicaid Medicare News Nutrition Pharmaceutical CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD Staff December 22, 2025 Diagnostics Fitness News Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship Staff December 22, 2025 Cancer Diagnostics DNA News Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach Staff December 22, 2025
